Chicago Capital LLC purchased a new position in Procter & Gamble Co (NYSE:PG) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 15,814 shares of the company’s stock, valued at approximately $1,254,000.
Several other institutional investors and hedge funds also recently modified their holdings of PG. Signature Financial Management Inc. grew its position in shares of Procter & Gamble by 155.6% during the first quarter. Signature Financial Management Inc. now owns 28,069 shares of the company’s stock valued at $2,225,000 after purchasing an additional 17,088 shares in the last quarter. Smith Salley & Associates grew its position in Procter & Gamble by 0.8% in the first quarter. Smith Salley & Associates now owns 120,027 shares of the company’s stock worth $9,515,000 after acquiring an additional 936 shares in the last quarter. Nippon Life Global Investors Americas Inc. lifted its stake in Procter & Gamble by 6.9% in the first quarter. Nippon Life Global Investors Americas Inc. now owns 151,130 shares of the company’s stock worth $11,982,000 after purchasing an additional 9,790 shares during the last quarter. Optimum Investment Advisors lifted its stake in Procter & Gamble by 10.6% in the first quarter. Optimum Investment Advisors now owns 9,180 shares of the company’s stock worth $728,000 after purchasing an additional 878 shares during the last quarter. Finally, Lee Financial Co lifted its stake in Procter & Gamble by 432.6% in the first quarter. Lee Financial Co now owns 8,783 shares of the company’s stock worth $696,000 after purchasing an additional 7,134 shares during the last quarter. 59.60% of the stock is currently owned by hedge funds and other institutional investors.
In other Procter & Gamble news, insider Gary A. Coombe sold 1,529 shares of the stock in a transaction that occurred on Monday, June 4th. The shares were sold at an average price of $74.25, for a total transaction of $113,528.25. Following the sale, the insider now directly owns 5,235 shares in the company, valued at approximately $388,698.75. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Price Matthew sold 11,626 shares of the stock in a transaction that occurred on Tuesday, August 7th. The shares were sold at an average price of $82.00, for a total transaction of $953,332.00. Following the completion of the sale, the insider now directly owns 27,496 shares in the company, valued at $2,254,672. The disclosure for this sale can be found here. Insiders sold a total of 94,035 shares of company stock worth $7,542,189 over the last quarter. 0.35% of the stock is currently owned by company insiders.
Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 31st. The company reported $0.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.04. The company had revenue of $16.50 billion during the quarter, compared to analysts’ expectations of $16.52 billion. Procter & Gamble had a net margin of 14.59% and a return on equity of 20.94%. Procter & Gamble’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.85 EPS. equities analysts forecast that Procter & Gamble Co will post 4.42 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 15th. Shareholders of record on Friday, July 20th will be issued a $0.7172 dividend. The ex-dividend date of this dividend is Thursday, July 19th. This represents a $2.87 annualized dividend and a yield of 3.52%. Procter & Gamble’s payout ratio is 68.01%.
Several analysts have issued reports on PG shares. Bank of America reissued a “neutral” rating and issued a $90.00 price objective on shares of Procter & Gamble in a research note on Thursday, April 19th. SunTrust Banks reaffirmed a “hold” rating and set a $75.00 target price on shares of Procter & Gamble in a research report on Friday, April 20th. Zacks Investment Research raised shares of Procter & Gamble from a “sell” rating to a “hold” rating in a report on Wednesday, April 18th. Jefferies Financial Group reissued a “buy” rating and set a $90.00 price objective on shares of Procter & Gamble in a report on Thursday, April 19th. Finally, Morgan Stanley reaffirmed a “hold” rating on shares of Procter & Gamble in a report on Monday, June 11th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $85.32.
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods to consumers in the United States, Canada, Puerto Rico, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company's Beauty segment offers hair care products, including conditioners, shampoos, styling aids, and treatments; and skin and personal care products, such as antiperspirant and deodorant, personal cleansing, and skin care products.
Featured Article: Diversification in Your Portfolio
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.